Table 2.
Year | MB (n/%) | PB (n/%) | Average delay time (months) | G2D (n/%) | No. of cases identified in skin clinics (n/%) | No. of new cases (n/%) |
---|---|---|---|---|---|---|
2005 | 26 (96.30) | 1 (3.70) | 23.44 | 7 (25.93) | 22 (81.48) | 27 (7.44) |
2006 | 25 (100.00) | 0 (0.00) | 25.64 | 11 (44.00) | 20 (80.00) | 25 (6.89) |
2007 | 33 (97.06) | 1 (2.94) | 64.68 | 12 (35.29) | 25 (73.53) | 34 (9.37) |
2008 | 27 (90.00) | 3 (10.00) | 33.13 | 9 (30.00) | 26 (86.67) | 30 (8.26) |
2009 | 34 (87.18) | 5 (12.82) | 88.38 | 19 (48.72) | 25 (64.10) | 39 (10.74) |
2010 | 31 (86.11) | 5 (13.89) | 54.19 | 13 (36.11) | 25 (69.44) | 36 (9.92) |
2011 | 23 (85.19) | 4 (14.81) | 41.56 | 12 (44.44) | 17 (62.96) | 27 (7.44) |
2012 | 25 (80.65) | 6 (19.35) | 29.42 | 8 (25.81) | 19 (61.29) | 31 (8.54) |
2013 | 20 (95.24) | 1 (4.76) | 27.81 | 2 (9.52) | 14 (66.67) | 21 (5.79) |
2014 | 24 (85.71) | 4 (14.29) | 34.29 | 6 (21.43) | 16 (57.14) | 28 (7.71) |
2015 | 12 (92.31) | 1 (7.69) | 23.62 | 2 (15.38) | 11 (84.62) | 13 (3.58) |
2016 | 12 (85.71) | 2 (14.29) | 37.21 | 5 (35.71) | 10 (71.43) | 14 (3.86) |
2017 | 14 (93.33) | 1 (6.67) | 45.53 | 2 (13.33) | 8 (53.33) | 15 (4.13) |
2018 | 10 (100.00) | 0 (0.00) | 79.60 | 4 (40.00) | 3 (30.00) | 10 (2.75) |
2019 | 5 (71.43) | 2 (28.57) | 45.29 | 2 (28.57) | 5 (71.43) | 7 (1.93) |
2020 | 6 (100.00) | 0 (0.00) | 25.33 | 1 (16.67) | 2 (33.33) | 6 (1.65) |
Total | 327 (90.08) | 36 (11.01) | 44.68 | 115 (31.68) | 248 (68.32) | 363 (100.00) |
G2D, grade 2 disability; MB, multibacillary; PB, paucibacillary.